AIR.NYSEAar CORP

Form 4: AAR CORP Director Hema Widhani Receives Stock Award

Sentiment:

Director Equity Grant


Director Hema Widhani was granted 1,364 phantom stock units as part of a restricted stock agreement.

Summary

  • Director Hema Widhani acquired 1,364 phantom stock units on June 1, 2026.
  • The units are granted pursuant to a restricted stock agreement.
  • The phantom stock units are payable on a 1-for-1 basis in either common stock or cash upon the director's retirement or termination.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified.

Risks

  • Value of phantom stock is tied to the future performance of AAR CORP common stock.

Future Outlook

The phantom stock units vest on June 1, 2027, and are payable upon the director's eventual retirement or termination from the board.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the aerospace and defense industry to ensure long-term alignment with company performance.

Comparison to Industry Standards

  • The use of phantom stock units is a common mechanism for director compensation among mid-cap aerospace firms.
  • The 1-for-1 conversion ratio is consistent with standard equity incentive plans.

Stakeholder Impact

  • Minimal impact on shareholders; represents standard director compensation.

Next Steps

  • Vesting of phantom stock units on June 1, 2027.

Key Dates

DateDescription
03/18/2025Date of Power of Attorney execution.
06/01/2026Date of transaction and commencement of vesting period.
06/01/2027Date units become exercisable.
05/31/2050Expiration date of the phantom stock units.

Keywords

AAR CORP, AIR, Director Compensation, Phantom Stock, Insider Transaction, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.